Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta
Biotech
Pfizer’s DMD gene therapy now ‘main game in town,' CSO says
With a confirmatory trial for Sarepta’s DMD trial ending in failure, Pfizer’s CSO says the pharma's gene therapy is now “the main game in town.”
Gabrielle Masson
Oct 31, 2023 2:28pm
Sarepta rewarded by Wall Street for FDA committee shocker
May 15, 2023 11:05am
FDA skips AdComm for Sarepta's DMD therapy, sets decision date
Feb 28, 2023 8:00pm
Lysogene looks for saving grace after trial flop
Dec 7, 2022 11:15am
With Sarepta in its sights, PepGen prices IPO to fund DMD trials
May 6, 2022 8:50am
Editas brings on Sarepta CMO—for CEO swap, not empty CMO role
Apr 14, 2022 10:35am